EUVIMEDEUVIMED entdecken
Crossref

Evaluation of lymphocyte crossmatch (CDCXM and Flow XM) test results before kidney transplantation

Ergun Mete

Pamukkale Medical Journal · 13.04.2026 · 19 (2) · 423-428

DOI: 10.31362/patd.1825119 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pamukkale Medical Journal, online erschienen am 13.04.2026. Verfasst von Ergun Mete. Die Arbeit nennt 29 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Detection of anti-HLA antibodies is crucial in pre-transplant immunological assessment to evaluate donor-recipient compatibility and prevent hyperacute rejection. This study aimed to evaluate lymphocyte crossmatch (XM) test results performed before kidney transplantation.Materials and methods: Lymphocyte crossmatch tests conducted at the Tissue Typing Laboratory of Pamukkale University Hospital between February 2020 and February 2024 were retrospectively analyzed. CDCXM (Complement-Dependent Cytotoxicity Crossmatch) and flow cytometric crossmatch (FCXM) tests were performed. For CDCXM, T and B lymphocytes were separated and tested individually, with serial dilution and DTT treatment applied. FCXM used anti-CD3 for T lymphocytes, anti-CD19 and anti-IgG for B lymphocytes, analyzed on a 10-color, 3-laser flow cytometer (Navios EX-Beckman Coulter, Inc. USA).

Results

A total of 225 CDCXM test results, 105 of which were alive and 120 of which were cadaver, were included in the study. CDCXM T and FCXM T were negative in living donors, while CDCXM B and FCXM B positivity were 4.8% and 2.6%, respectively. CDCXM T and B positivity in cadaveric donors were 3.3% and 7.5%, respectively, and FCXM T and B positivity were 3.3% and 8.8%, respectively.

Conclusion

Lymphocyte crossmatch remains a reliable and classical method for pre-transplant immunological evaluation. It effectively detects donor-specific anti-HLA antibodies and contributes to the prevention of hyperacute rejection in kidney transplantation.

Zitieren

APA

Mete, E. (2026). Evaluation of lymphocyte crossmatch (CDCXM and Flow XM) test results before kidney transplantation. Pamukkale Medical Journal, 19(2), 423-428. https://doi.org/10.31362/patd.1825119

Vancouver

Mete E. Evaluation of lymphocyte crossmatch (CDCXM and Flow XM) test results before kidney transplantation. Pamukkale Medical Journal. 2026;19(2):423-428. doi:10.31362/patd.1825119

BibTeX
@article{Mete2026,
  author = {Mete, Ergun},
  title = {Evaluation of lymphocyte crossmatch (CDCXM and Flow XM) test results before kidney transplantation},
  journal = {Pamukkale Medical Journal},
  year = {2026},
  volume = {19},
  number = {2},
  pages = {423--428},
  doi = {10.31362/patd.1825119}
}
Kostenlos starten →